Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) saw a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 100 shares, a drop of 97.6% from the May 15th total of 4,100 shares. Currently, 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.
Basilea Pharmaceutica Price Performance
Shares of BPMUF remained flat at $57.70 during mid-day trading on Friday. Basilea Pharmaceutica has a 52 week low of $47.50 and a 52 week high of $57.70. The business has a 50-day simple moving average of $49.79 and a two-hundred day simple moving average of $51.87. The company has a debt-to-equity ratio of 5.70, a current ratio of 4.10 and a quick ratio of 3.27.
About Basilea Pharmaceutica
(
Get Free Report)
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Further Reading
Before you consider Basilea Pharmaceutica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Basilea Pharmaceutica wasn't on the list.
While Basilea Pharmaceutica currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
